Follow the 台康生技 stock price and the full insider trade history of the company, a publicly traded company based in Taiwan. Shares are listed on the TW market, under the supervision of TWSE / TPEx (MOPS). Market capitalisation: €15.4bn. The latest transaction was filed on 13 May 2026 (Gift). Among the most active insiders: 劉理成. The full history is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 26,952 of 28,752 companies
17.4
score / 100
Value
19
Quality
16
FCF yld-8.7%
Earn yld-5.0%
EV/EBITDA·
ROE-7.0%
Gross mgn19%
Net mgn-76%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Taiwan Biotech is a company listed on the XTAI market, specializing in the biotechnology sector. It focuses on developing innovative products to enhance human health.